• 4
    Esin Aki-Yalcin, Ismail Yalcin, “DNA topoisomerase inhibitory activity and 3D-QSAR analysis of benzazoles”, Macedonian pharmaceutical bulletin, 62 (suppl): 535-536, (2016). [texto íntegro]
  • 3
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Esin Aki-Yalcin, Ufuk Over-Hasdemir, “Binding site description of 2-substituted benzothiazoles as potential RND efflux pump inhibitors”, Macedonian pharmaceutical bulletin, 62 (suppl): 543-544, (2016). [texto íntegro]
  • 2
    Esin Aki-Yalcin, Ozum Ozturk, Kayhan Bolelli, Ismail Yalcin, “Docking studies of neurokinin-1 receptor antagonists as an anticancer target”, Macedonian pharmaceutical bulletin, 62 (suppl): 553-554, (2016). [texto íntegro]
  • 1
    Ismail Yalcin, Tugba Ertan-Bolelli, Esin Aki-Yalcin, “New human Glutathione-S-transferase P1-1 inhibitors and their ligand binding site and GSH complex formation descriptions”, Macedonian pharmaceutical bulletin, 62 (suppl): 571-572, (2016). [texto íntegro]